24/7 Vacations Web Search

Search results

1. Results from the 24/7 Vacations Content Network

2. Bristol Myers sales fall, cuts 2023 forecast as drugs face ...

   www.aol.com/news/bristol-myers-sales-fall-cuts...

   (Reuters) -Bristol Myers Squibb on Thursday said its second-quarter sales fell more than expected and cut its full-year forecasts as two of its top drugs, the blood cancer treatment Revlimid and ...

3. Bristol Myers accused of illegal tactics to keep Pomalyst ...

   www.aol.com/news/bristol-myers-accused-illegal...

   Bristol Myers Squibb has been accused in a new lawsuit of using fraudulent patents and other illegal tactics to maintain its monopoly on blockbuster blood cancer drug Pomalyst for years after it ...

4. Bristol Myers Squibb - Wikipedia

   en.wikipedia.org/wiki/Bristol_Myers_Squibb

   The Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb ( BMS ), is an American multinational pharmaceutical company. Headquartered in Princeton, New Jersey, [ 2] BMS is one of the world's largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations.

5. Apixaban - Wikipedia

   en.wikipedia.org/wiki/Apixaban

   Apixaban, sold under the brand name Eliquis, is an anticoagulant medication used to treat and prevent blood clots and to prevent stroke in people with nonvalvular atrial fibrillation through directly inhibiting factor Xa. [6] [7] [8] Specifically, it is used to prevent blood clots following hip or knee replacement and in those with a history of ...

6. US FDA approves Bristol Myers' colorectal cancer therapy

   www.aol.com/news/us-fda-approves-bristol-myers...

   By Christy Santhosh and Unnamalai L. (Reuters) -The U.S. Food and Drug Administration has approved Bristol Myers Squibb's combination therapy for treating colorectal cancer in patients with a ...

7. US FDA approves expanded use of Bristol Myers' cancer cell ...

   www.aol.com/news/us-fda-approves-expanded...

   By This, May, 15, story and has. (Reuters) - The U.S. health regulator on Wednesday approved the expanded use of Bristol Myers Squibb's cancer cell therapy Breyanzi for the treatment of adults ...

8. US FDA allows J&J, Bristol Myers cell therapies as early ...

   www.aol.com/news/us-fda-allows-expanded-bristol...

   The U.S. Food and Drug Administration has allowed the cell therapies of Johnson & Johnson and Bristol Myers Squibb to be used as earlier lines of treatments in patients with a type of blood cancer ...

9. Bristol Myers' Opdivo extends survival in bladder cancer study

   www.aol.com/news/bristol-myers-bladder-cancer...

   The drug, first approved in 2014, is one of the top selling treatments for Bristol Myers, with analysts forecasting $8.3 billion in sales for the year, according to Refinitiv estimates.